Serum Alpha-1-Antitriypsin Levels in Patients with Pseudoexfolative Syndrome

REFERENCES

• Travis J, Salvesen G S. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655–709
   PubMed Web of Science ®Google Scholar
• Littleton E T, Bevis L, Hansen L J, et al. Alpha-1-antitrypsin deficiency, complement activation, and chronic liver disease. J Clin Pathol. 1991; 44: 855–858
   Google Scholar
• Boskovic G, Twinning S S. Local control of alpha-1 proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim Biopsy Acta. 1998; 1403: 37–46
   PubMed Web of Science ®Google Scholar
• Ando H, Twinning S S, Yue B Y, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci 1993; 34: 3541–3548
   PubMed Web of Science ®Google Scholar
• Clausen R, Weller M, Wiedeman P, et al. An immunochemical quantitative analysis of the protein pattern in physiologicand pathologic vitreous. Graefes Arch Clin Exp Ophthalmol 1991; 229: 186–190
   PubMed Web of Science ®Google Scholar
• Schlotzer-Schrehardt U M, Koca M R, Naumann G OH, et al. Pseudoexfoliation syndrome: Ocular manifestation of a systemic disorder?. Arch Ophthalmol. 1992; 110: 1752–1756
   PubMed Web of Science ®Google Scholar
• Streeten B W, Li Z Y, Wallace R N, et al. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992; 110: 1757–1762
   PubMed Web of Science ®Google Scholar
• Damji K F, Bains H S, Stefansson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet. 1998; 19: 175–185
   PubMedGoogle Scholar
• Janciauskiene S, Krakau T. Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome. Doc Ophthalmol 2003; 106: 215–223
   PubMedGoogle Scholar
• Schlotzer-Schrehardt U, Külche M, Dorfler S, et al. GOH. Pseudoexfoliative material in the eyelid skin of pseudoexfoliation-suspect patients: A clinico-histopathological correlation. Germ J Ophthalmol. 1993; 2: 51–60
   Google Scholar
• Fearnley I R, Spalton D J, Ward A M, et al. Alpha-1-antitrypsin phenotypes in acute anterior uveitis. Br J Ophthalmol. 1988; 72: 636–639
   Google Scholar
• Evereklioglu C, Turkoz Y, Er H, et al. Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker?. J Am Acad Dermatol. 2002; 46: 50–54
   PubMed Web of Science ®Google Scholar
• Drolsum L, Haaskjold E, Sandvig K. Phacoemulsification in eyes with pseudoexfoliation. J Cataract Refract Surg. 1998; 24: 787–792
   PubMed Web of Science ®Google Scholar
• Abela-Formanek C, Amon M, Schauersberger J, et al. Postoperative inflammatory response to phacoemulsification and implantation of 2 types of foldable intraocular lenses in pseudoexfoliation syndrome. Klin Monatsbl Augenheilkd. 2000; 217: 10–14
   Google Scholar
• Pierce J A. Antityripsin and emphysema. Perspective and prospects. JAMA. 1998; 259: 2890–2895
   Google Scholar
• Funding M, Vorum H, Nexo E, et al. Alpha-1-antitrypsin in aqueous humor from patients with corneal allograft rejection. Acta Ophthalmol Scand. 2005; 83: 379–384
   Google Scholar
• Evereklioglu C, Inaloz H S, Kirtak N, et al. Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity. Br J Dermatol 2002; 147: 331–336
   PubMedGoogle Scholar
• Janciauskiene S, Krakau T. Alzheimer's peptide: A possible link between glaucoma, exfoliation syndrome and Alzheimer's disease. Acta Ophthalmol Scand. 2001; 79: 328–329
   PubMedGoogle Scholar
• Giometto B, Argentiero V, Sanson F, et al. Acute-phase proteins in Alzheimer's disease. Eur Neurol. 1988; 28: 30–33
   Google Scholar
• Licastro F, Masliah E, Pedrini S, et al. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: Effects of gender and apolipoprotein E genotype. Dement Geriatr Cogn Disord 2000; 11: 25–28
   Google Scholar
• Fiore P M, Melamed S, Epstein D L. Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty. Ophthalmic Surg 1989; 20: 697–701
   PubMedGoogle Scholar
• Drolsum L, Davanger M, Haaskjold E. Risk factors for an inflammatory response after extracapsular cataract extraction and posterior chamber IOL. Acta Ophthalmol (Copenh) 1993; 71: 771–776
   Google Scholar
• Ritch R, Schlötzer-Screhardt U. Exfoliation syndrome. Surv Ophthalmol. 2001; 45: 265–315
   PubMed Web of Science ®Google Scholar
• Cumurcu T, Sahin S, Aydin E. Serum homocysteine, vitamin B12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 2006; 6: 6
   PubMedGoogle Scholar
• Puustjarvi T, Blomster H, Kontkanae M, Punnonen K, Terasvirta M. Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 2004; 242: 749–754
   PubMed Web of Science ®Google Scholar
• Yxfeldt A, Wallberg-Jonsson S, Hultdin J, Rantapaa-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 2003; 32: 205–210
   PubMed Web of Science ®Google Scholar
• Su S J, Huang L W, Pai L S, Liu H W, Chang K L. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition. 2005; 21: 994–1002
   PubMedGoogle Scholar
• Holven K B, Aukrust P, Retterstol K, Hangve T A, Morkid L, Ose L, Nenseter M S. Scand J Clin Lab Invest 2006; 66: 45–54
   PubMed Web of Science ®Google Scholar
• Tso T K, Huang W N, Huang H Y, Chang C K. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology 2006; 45: 1148–1153
   PubMed Web of Science ®Google Scholar
• Schlotzer-Schrehardt U, Naumann G O. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141: 921–937
   PubMed Web of Science ®Google Scholar